 Cardiovascular disease is the leading cause of death in the U.S., and it accounts for billions of dollars in spending. That's why it's crucial for clinical leaders and policymakers to take note of these worrisome trends and address their impact on the health and economic well-being of the nation. An aging population and other demographic shifts drive the forecast, along with a concerning rise in risk factors for CBD, particularly among younger people.